PD-L1- and IL-4-expressing basophils promote pathogenic accumulation of T follicular helper cells in lupus.
John TchenQuentin SimonLéa ChapartMorgane K ThaminyShamila VibhushanLoredana SaveanuYasmine LamriFanny SaidouneEmeline PacreauChristophe PellefiguesJulie Bex-CoudratHajime KarasuyamaKensuke MiyakeJuan HidalgoPadraic G FallonThomas PapoUlrich BlankMarc BenhamouGuillaume HanounaKarim SacreEric DaugasNicolas CharlesPublished in: Nature communications (2024)
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by anti-nuclear autoantibodies whose production is promoted by autoreactive T follicular helper (TFH) cells. During SLE pathogenesis, basophils accumulate in secondary lymphoid organs (SLO), amplify autoantibody production and disease progression through mechanisms that remain to be defined. Here, we provide evidence for a direct functional relationship between TFH cells and basophils during lupus pathogenesis, both in humans and mice. PD-L1 upregulation on basophils and IL-4 production are associated with TFH and TFH2 cell expansions and with disease activity. Pathogenic TFH cell accumulation, maintenance, and function in SLO were dependent on PD-L1 and IL-4 in basophils, which induced a transcriptional program allowing TFH2 cell differentiation and function. Our study establishes a direct mechanistic link between basophils and TFH cells in SLE that promotes autoantibody production and lupus nephritis.
Keyphrases
- systemic lupus erythematosus
- disease activity
- induced apoptosis
- rheumatoid arthritis
- cell cycle arrest
- rheumatoid arthritis patients
- ankylosing spondylitis
- stem cells
- multiple sclerosis
- juvenile idiopathic arthritis
- endoplasmic reticulum stress
- oxidative stress
- healthcare
- cell proliferation
- cell therapy
- regulatory t cells
- bone marrow
- transcription factor
- mesenchymal stem cells
- poor prognosis
- drug induced
- health insurance
- stress induced
- high glucose